Log In Sign up
The largest database of trusted experimental protocols

Brdu elisa assay kit

Manufactured by Cell Signaling Technology
Visit Supplier
Sourced in China

The BrdU ELISA assay kit is a laboratory tool designed to detect and quantify the incorporation of the synthetic nucleoside bromodeoxyuridine (BrdU) into cellular DNA. This kit utilizes an enzyme-linked immunosorbent assay (ELISA) format to measure the amount of BrdU present in samples, providing a reliable method for analyzing cell proliferation and DNA synthesis.

Automatically generated - may contain errors

Lab products found in correlation

M csf, by Thermo Fisher Scientific (1 mentions) Brdu cell proliferation assay kit, by GE Healthcare (1 mentions)

Spelling variants of this product

BrdU assay kit (9 citations) BrdU ELISA kit (5 citations) BrdU assay (5 citations) ELISA (BrdU Cell Proliferation Assay Kit, (4 citations)

5 protocols using brdu elisa assay kit

1

Quantifying Osteoclast Precursor Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Osteoclast precursor proliferation was quantified using a BrdU Cell Proliferation Assay kit (GE Healthcare Life Sciences, Piscataway, NJ, USA) [43 (link)]. BMMs were treated with 30 ng/mL of M-CSF (PeproTech, Rocky Hill, NJ, USA) for 3 days in the presence or absence of 2N1HIA. Cell proliferation was quantified from BrdU incorporation using the BrdU ELISA assay kit (Cell Signaling Technology, Boston, MA, USA).
Ahn S.H., Chen Z., Lee J., Lee S.W., Min S.H., Kim N.D, & Lee T.H. (2018). Inhibitory Effects of 2N1HIA (2-(3-(2-Fluoro-4-Methoxyphenyl)-6-Oxo-1(6H)-Pyridazinyl)-N-1H-Indol-5-Ylacetamide) on Osteoclast Differentiation via Suppressing Cathepsin K Expression. Molecules, 23(12), 3139.
+ Open protocol
+ Expand
2

Cell Proliferation Assay using BrdU ELISA

Check if the same lab product or an alternative is used in the 5 most similar protocols
To assay of cell proliferation, BrdU ELISA assay kit (Cell Signaling, Nanjing, China) was used [44 (link)]. The ELISA OD value of treatment group was always normalized to percentage of untreated control group.
Xiong Z., Zang Y., Zhong S., Zou L., Wu Y., Liu S., Fang Z., Shen Z., Ding Q, & Chen S. (2017). The preclinical assessment of XL388, a mTOR kinase inhibitor, as a promising anti-renal cell carcinoma agent. Oncotarget, 8(18), 30151-30161.
+ Open protocol
+ Expand
3

BrdU ELISA for Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
BrdU ELISA assay kit, purchased from the Cell Signaling Tech, was applied to test cell proliferation after CC223 treatment [49 (link)]. The ELISA OD value at 450 nM was recorded as the indicator of cell proliferation.
Jin Z., Niu H., Wang X., Zhang L., Wang Q, & Yang A. (2017). Preclinical study of CC223 as a potential anti-ovarian cancer agent. Oncotarget, 8(35), 58469-58479.
+ Open protocol
+ Expand
4

Cell Proliferation Quantification via BrdU ELISA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells with the GSK1904529A treatment were also subjected to BrdU ELISA assay kit (Cell Signaling Tech, Wuxi, China) via the attached protocol [29 (link)]. BrdU ELISA OD at 405 nm was recorded to quantify cell proliferation.
Fei H.D., Yuan Q., Mao L., Chen F.L., Cui Z.H., Tao S, & Ji F. (2017). Assessment of GSK1904529A as a promising anti-osteosarcoma agent. Oncotarget, 8(30), 49646-49654.
+ Open protocol
+ Expand
5

Cell Proliferation Quantification via BrdU ELISA

Check if the same lab product or an alternative is used in the 5 most similar protocols
BrdU ELISA assay kit, purchased from Cell Signaling Tech (Nanjing, China) was applied to quantify cell proliferation [41 (link)]. The ELISA OD value of treatment group (at 405 nm) was always normalized to control group.
Yin G., Fan J., Zhou W., Ding Q., Zhang J., Wu X., Tang P., Zhou H., Wan B, & Yin G. (2017). ERK inhibition sensitizes CZ415-induced anti-osteosarcoma activity in vitro and in vivo. Oncotarget, 8(47), 82027-82036.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!